ISO 14937: Sterilizing Agent Characterization for Medical Devices

ISO 14937: Sterilizing Agent Characterization for Medical Devices

Quick Summary: ISO 14937 is the general standard for sterilizing agents that do not have a dedicated modality standard. It covers how an agent is characterised, how a process built on it is developed and validated, and how that process is controlled in routine use. This guide explains what the standard requires in plain language, why it matters to a clinic even when the clinic never opens it, and what to ask a supplier whose product depends on it.

A clinic invests in a low-temperature sterilizer for instruments that cannot take steam. The unit arrives with a manual, a set of cycle parameters and a monitoring recommendation. Somewhere behind that manual is a chain of reasoning that begins with the properties of a sterilizing agent and ends with a printed record from a Tuesday afternoon cycle. ISO 14937 is the standard that describes how that chain is built.

Most sterilization standards are modality-specific. Moist heat has its own framework, ethylene oxide has its own, radiation has its own. That works while the industry stays inside those three families. When a new agent appears, or when a process is used that has no dedicated standard yet, there has to be a general standard that says how any sterilizing agent should be characterised and how any process built on it should be developed, validated and controlled (ISO 14937:2009).

The need is not academic. Reprocessing sits inside infection prevention expectations that treat instrument handling as a controlled process rather than a cleaning chore, as Canadian public health guidance for dental settings makes clear (Public Health Ontario dental IPAC checklist), and as occupational health material on biological hazards reinforces from the worker-protection side (CCOHS biological hazards).

What does ISO 14937 actually require?

The standard is structured around four blocks. Characterisation establishes what the agent is and how it behaves. Development turns that understanding into a process with defined parameters. Validation demonstrates that the process delivers the required sterility assurance under real operating conditions. Routine control keeps the validated process inside its envelope, cycle after cycle, with records.

The order is not decorative. A process cannot be validated against a variable nobody has characterised, and routine monitoring cannot detect drift unless the validated parameters were defined in the first place. When a facility asks why the record-keeping matters so much, the answer is that the records are the evidence that the chain held.

There is also a workplace exposure dimension. Some sterilizing agents are hazardous, which is why the standard sits alongside occupational health material on biological and chemical hazards rather than replacing it (CCOHS biological hazards). The World Health Organization's infection prevention guidance takes the same layered view of controls in health care settings (WHO infection prevention and control).

Who actually uses the standard?

In day-to-day terms, manufacturers and reprocessors do. A device manufacturer validating a new low-temperature process, a contract sterilizer adding a modality, or a packaging supplier qualifying a material for a vapour process are all working inside the general framework. The output is the documentation that eventually lands in a clinic as an instruction sheet.

That is how the standard reaches a dental office or a veterinary clinic. It arrives as the validated parameters on a sterilizer, as the modality qualification on a pouch, or as the specified cycle on a biological indicator's instructions for use. When one of those documents is silent or inconsistent, the standard is what explains why the question is worth asking.

If you are comparing packaging options for a specific process, seal strength and package integrity have their own methods, including seal strength testing under ASTM F88 (ASTM F88) and gross leak detection by internal pressurisation under ASTM F2096 (ASTM F2096). Those tests describe the barrier, not the sterilizing agent, and both questions have to be answered separately.

Why should a clinic care about a standard it never opens?

Because the standard explains the shape of the paperwork a clinic is asked to keep, and the shape of the questions an inspector or accreditation reviewer will ask. Records that show cycle parameters, monitoring results and corrective actions are not bureaucratic decoration; they are the visible end of a validation chain that starts with agent characterisation.

It also explains why substitution is risky. Changing a cycle, switching to a pouch qualified for a different modality, or using an indicator qualified for another process breaks the link between what was validated and what happened. The result can still look fine on the printout while the assurance behind it has quietly disappeared.

Finally, it gives a buyer a vocabulary. A supplier who can name the modality, the validated parameters, the specified monitoring and the supporting documentation is describing a process. A supplier who describes only a product is describing a hope. Asking the four questions costs nothing and separates the two.

What belongs in a facility's reprocessing file?

Most of what a Canadian clinic needs is already familiar: cycle logs, indicator results, spore testing records, maintenance records and the manufacturer's instructions for the equipment in use. The validation layer sits underneath those documents rather than beside them.

• The sterilizer's validated cycle parameters, as supplied and as configured on your unit.
• The packaging system in use and the modality it is qualified for.
• The monitoring products in use, with their specified modality and cycle type.
• Records of repairs or changes that could alter the validated process, with the re-verification that followed.
• A written change-control habit: when something in that list changes, the file records what changed and why.

That last item is the one most often missing and the one that usually triggers a finding, because it is the only evidence that the facility was paying attention between inspections.

ISO 14937 does not ask a dental office to become a validation laboratory. It asks that the process behind the instruments be characterised, validated and controlled, and that the evidence exist somewhere in the chain. Most clinics satisfy that requirement through good documentation discipline and a supplier who can answer questions in writing. CliniEco Medical supplies Canadian clinics, laboratories, long-term care homes and veterinary practices with the monitoring and packaging side of that chain: 3-hour rapid readout fluorescence biological indicators, the 24-hour biological indicator incubator, and Class 4 dual-indicator sterilization pouches. If you want to test a monitoring routine before committing to a case, the biological indicator 5-pack trial is CA $12.99 with shipping included. Facility and wholesale enquiries go through the bulk quote request page.

References and standards cited

1. ISO 14937:2009, Sterilization of health care products — General requirements for characterization of a sterilizing agent and the development, validation and routine control of a sterilization process for medical devices (link checked 19 September 2026)
2. ASTM F1980, Standard Guide for Accelerated Aging of Sterile Barrier Systems and Medical Devices (link checked 19 September 2026)
3. ASTM F88, Standard Test Method for Seal Strength of Flexible Barrier Materials (link checked 19 September 2026)
4. ASTM F2096, Standard Test Method for Detecting Gross Leaks in Packaging by Internal Pressurization (Bubble Test) (link checked 19 September 2026)
5. Public Health Ontario, Infection prevention and control (link checked 19 September 2026)
6. Public Health Ontario, IPAC checklist for reprocessing in dental settings (PDF) (link checked 19 September 2026)
7. World Health Organization, Infection prevention and control fact sheet (link checked 19 September 2026)
8. Canadian Centre for Occupational Health and Safety, Biological hazards (link checked 19 September 2026)
9. OSHA, Bloodborne Pathogens standard (29 CFR 1910.1030) (link checked 19 September 2026)
10. Health Canada, Medical devices (federal device framework) (link checked 19 September 2026)

Related Reading

• Sterilization Modalities: ISO 17665, ISO 11135 and ISO 11137
• Seal Integrity Testing for Sterile Pouches: ASTM F88, F1929 and F1886
• ISO 11138 Series Explained: What Parts 1, 2, 3 and 4 Actually Require
• Sterility Assurance Level 10-6, Log Reduction and D-Value: What the Numbers Mean
• CliniEco Medical Biological Indicator — 3-Hour Rapid Readout, Fluorescence, 50-Pack
• CliniEco 24-Hour Biological Indicator Incubator — Precision Dry Block, 24 wells
• Medical Sterilization Pouch — Class 4 Dual Indicator, Assorted Sizes, 200-Pack
• Wholesale and facility accounts
• free Ontario sterilization compliance log
• printable autoclave sterilization log sheet (free)

Frequently Asked Questions

What does ISO 14937 cover that the modality standards do not?

The modality standards are written for specific processes such as moist heat, ethylene oxide and radiation. ISO 14937 is the general standard for sterilizing agents that do not yet have a dedicated standard of their own, and for new processes as they are introduced. It sets out how to characterise the agent, how to develop and validate a process built on it, and how to run routine control, without prescribing the parameters of any one technology.

What does characterization of a sterilizing agent actually mean?

It means establishing what the agent is and how it behaves: its identity, how it is generated, how its concentration or dose is measured, what conditions it needs to work, and what evidence shows that it destroys microorganisms. Characterisation is the foundation, because a process cannot be validated against a variable nobody has characterised.

Does a dental clinic need to work with ISO 14937 directly?

A clinic running a benchtop steam sterilizer works inside the moist heat framework and its own provincial expectations. ISO 14937 is more likely to reach a clinic indirectly, through a device manufacturer's validation file, through a packaging material qualified for a specific process, or through the instructions for use that arrive with a monitoring product. Knowing the standard exists helps a buyer ask better questions.

How does routine monitoring fit into the standard?

Routine control is one of the blocks the standard covers, alongside characterisation, development and validation. It is the part that continues after the validation report is signed: defined parameters monitored every cycle, indicators and biological indicators appropriate to the modality, records that show the process stayed inside its validated envelope.

Why does packaging compatibility come up in a sterilization standard?

Because a sterile barrier has to survive the process it goes through. A pouch qualified for steam is not automatically qualified for a low-temperature vapour process, and the packaging standard expects the packaging system to be validated for the specific sterilization method. Seal strength and package integrity then get tested with their own methods, such as ASTM F88 for seal strength and ASTM F2096 for gross leaks.

Can a clinic use a new low-temperature sterilizer without a validation file?

The equipment is normally supplied with a documented process and parameters that the manufacturer has validated. What a facility has to do is run the process as specified, monitor it as specified, and keep the records. Substituting a cycle, changing packaging, or using a monitoring product qualified for a different modality breaks the link between the validated process and what actually happened in the room.

How is this different from accelerated aging and shelf-life testing?

Different question entirely. Accelerated aging, for which ASTM F1980 is the common guide, asks how long a sterile barrier keeps its integrity over time. ISO 14937 asks whether the sterilization process itself is characterised, developed, validated and routinely controlled. A facility needs both answers, but they come from different evidence.

What should a buyer ask a supplier about sterilization validation?

Ask which modality the product or packaging is validated for, what the validated parameters are, which monitoring is specified, and what documentation supports the claim. Then confirm the supplier's device registration where applicable, since devices sold in Canada sit inside the federal device framework. A supplier who can answer those four questions in writing is a supplier whose product can be traced to a process rather than to a description.

Last updated: September 2026. CliniEco Medical is a licensed medical device establishment (MDEL #35334).